ReviewFrontiers in oncology2026
Predictive modeling for survival-related outcomes in lung cancer patients with brain metastases: a mini-review.
Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Predicting survival in lung cancer patients, particularly those with brain metastases, is crucial for personalizing treatment plans and estimating patient prognosis. This minireview synthesizes findings from fifteen recent studies published between 2020 and 2026, focusing on survival prediction in lung cancer patients with brain metastases, with key outcomes including overall survival, progression-free survival, and intracranial progressionfree survival. Traditional and current approaches for predicting survival are discussed, along with comparisons between unimodal and multimodal approaches. Moreover, the strengths and limitations of existing methods are critically analyzed. The findings emphasize the potential of advanced predictive modeling to inform personalized treatment plans and improve survival outcomes in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.